Latest Advances

  • Condition: Patient with Corneal Ectasia Associated with Stevens-Johnson Syndrome
  • Journal: Optometry and vision science : official publication of the American Academy of Optometry
  • Treatment Used: Corneal Crosslinking
  • Number of Patients: 1
  • Published —
This case report describes a 25-year-old Indian man with Stevens-Johnson syndrome (skin disorder) diagnosed with associated corneal ectasia (thinning) treated with accelerated epithelium-off corneal crosslinking.
  • Condition: Advanced Esophageal Squamous Cell Carcinoma
  • Journal: Cancer communications (London, England)
  • Treatment Used: Camrelizumab Combined with Apatinib and Chemotherapy
  • Number of Patients: 30
  • Published —
In this study, researchers evaluated the outcomes of using camrelizumab combined with apatinib and chemotherapy for the treatment of advanced esophageal squamous cell carcinoma.
  • Condition: Total Symblepharon and Lid Margin Keratinization after Stevens-Johnson Syndrome
  • Journal: BMJ case reports
  • Treatment Used: Oral Mucous Membrane Grafts
  • Number of Patients: 1
  • Published —
This case report describes a patient with total symblepharon and lid margin keratinization after Stevens-Johnson syndrome that was treated using oral mucous membrane grafts.
  • Condition: Residual Disease in Adults with Acute Lymphoblastic Leukemia
  • Journal: Blood advances
  • Treatment Used: Pembrolizumab
  • Number of Patients: 0
  • Published —
The study researched the safety and effectiveness of pembrolizumab for patients with residual disease in adults with acute lymphoblastic leukemia.
  • Condition: Nephrotic Syndrome and Hyperlipidemia
  • Journal: Annals of palliative medicine
  • Treatment Used: Proportein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor
  • Number of Patients: 1
  • Published —
This case report describes a patient with nephrotic syndrome and hyperlipidemia.
  • Condition: Drug-Induced Bullous Pemphigoid with Multiple Sclerosis
  • Journal: Multiple sclerosis and related disorders
  • Treatment Used: Teriflunomide
  • Number of Patients: 1
  • Published —
This case report describes a patient that used teriflunomide for multiple sclerosis and experienced drug-induced bullous pemphigoid as a result.
  • Condition: Oculoplastic and Ocular Surface Disease
  • Journal: Advances in therapy
  • Treatment Used: Surgery after Type I Boston Keratoprosthesis Implantation
  • Number of Patients: 29
  • Published —
This study tested the safety and efficacy of using surgical management to treat patients that developed oculoplastic and ocular surface disease after a type I Boston keratoprosthesis implantation.
  • Condition: Multiple Actinic Keratoses
  • Journal: Acta dermatovenerologica Alpina, Pannonica, et Adriatica
  • Treatment Used: Imiquimod
  • Number of Patients: 1
  • Published —
This article reviewed the case of a patient with multiple actinic keratoses (pre-cancerous area of thick, scaly, or crusty skin) who developed erythema multiforme (type of allergic reaction located in skin) after treatment with imiquimod.
  • Condition: Anti-Epileptic Drug (AED) Induced Skin Reactions
  • Journal: Seizure
  • Treatment Used: Alternative Medication
  • Number of Patients: 0
  • Published —
This study provides a summary of severe delayed allergic reactions and offers a pragmatic management pathway for patients suffering a suspected drug-induced rash from anti-epileptic drugs (AED).
  • Condition: Stevens-Johnson syndrome/toxic epidermal necrolysis
  • Journal: BMJ case reports
  • Treatment Used: low-dose corticosteroids, vitamin C and thiamine
  • Number of Patients: 1
  • Published —
The purpose of the study was to report a case of a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis successfully treated with low-dose corticosteroids, vitamin C and thiamine.
  • Condition: Metastatic Melanoma
  • Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
  • Treatment Used: Combination Ipilimumab and Nivolumab
  • Number of Patients: 1
  • Published —
This case report describes a patient with metastatic melanoma that was treated using a combination ipilimumab and nivolumab.
Showing 1-12 of 24